John Wang
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
59
Citations
1,327
Est. group size
—
Recurring co-author estimate
Active years
31
Publishing since 1995
John Wang works in cancer biology and immunology, with a focus on activating the immune system to fight tumors. A central line of research involves stimulating the STING pathway (a molecular sensor that triggers immune responses) to treat non-muscle-invasive bladder cancer in mouse models. Related work touches on cancer treatment, immune cell responses, and applying language-processing tools to medical text.
Publication output has been irregular, with a notable spike in 2023 and continued activity into 2025, averaging about 5.4 papers per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Using LLMs to Extract Adverse Drug Reaction (ADR) from Short Text
2025
- Supplementary Figure from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
2025
- Supplementary Table from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
2025
- Supplementary Figure from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
2025
- Supplementary Figure from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
2025
- Supplementary Figure from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
2025
- Primary uveal lymphoma mimicking uveitis with hypopyon
Eye · 2025
- Supplementary Table from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
2023
- Supplementary Figure from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
2023
- Supplementary Figure from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
2023
- Supplementary Figure from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
2023
- Supplementary Figure from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
2023
- Supplementary Figure from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
2023
- Supplementary Table from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
2023
- Supplementary Figure from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
2023
- IUPAC Standards Online×5
- Cancer Research×3
- Pharmaceutical Research×1
- Canadian Medical Association Journal×1
- Environment International×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile